Skip to content

Clinical trials

Terminated Phase 3 trials in Belarus

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Terminated Country / region: Belarus Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20092
20121
20171
20184
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Forest Laboratories2
AbbVie1
Ambrilia Biopharma, Inc.1
La Jolla Pharmaceutical Company1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1
Sanofi1
Teva Branded Pharmaceutical Products R&D, Inc.1
Tricida, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease3
Diabetes Mellitus, Type 22
Acidosis1
Acromegaly1
Atrial Fibrillation1
Lupus Erythematosus, Systemic1
Lupus Nephritis1
Multiple Sclerosis, Relapsing-Remitting1
Neoplasms1
Nephritis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.